-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E4/wDf6JXIS3w3/evza6TMkw3rgC6frDdEYo9ZwbZL4zoP1w7hAyaDuDCInA+pG3 naVXDYa3KjDFfXNDcfomkw== 0000950133-06-003740.txt : 20060811 0000950133-06-003740.hdr.sgml : 20060811 20060811161237 ACCESSION NUMBER: 0000950133-06-003740 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060630 FILED AS OF DATE: 20060811 DATE AS OF CHANGE: 20060811 EFFECTIVENESS DATE: 20060811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06964 FILM NUMBER: 061025245 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 13F-HR 1 w23864e13fvhr.txt 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2006 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger Title: SIGNING AUTHORITY -------------------------------------------- Phone: 41 (01) 267 67 00 Signature, Place, and Date of Signing: /s/ Adrian Bruengger ----------------------------------------- Schaffhausen, Switzerland, August 3, 2006 FORM 13F SUMMARY PAGE Report Type (Check only one.): [x] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 19 Form 13F Information Table Value Total: $1,524,454 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V.
BB BIOTECH AG FORM 13F INFORMATION TABLE - ------------------------------------------------------------------------------------------------------------------------------------ COLUMN 8 COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 VOTING AUTHORITY - ------------------------------------------------------------------------------------------------------------------------------------ NAME OF TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER ISSUER CLASS CUSIP [x$1000] PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ------------------------------------------------------------------------------------------------------------------------------------ Adolor Corp. COM 00724X102 25,010 1,000,000 SH DEFINED 3 1,000,000 NONE NONE Affymetrix COM 00826T108 51,200 2,000,000 SH DEFINED 1 2,000,000 NONE NONE Amgen COM 031162100 81,538 1,250,000 SH DEFINED 1 1,250,000 NONE NONE Anadys Pharmaceuticals COM 03252Q408 5,840 2,000,000 SH DEFINED 3 2,000,000 NONE NONE Arena Pharmaceuticals COM 040047102 11,580 1,000,000 SH DEFINED 3 1,000,000 NONE NONE Biogen Idec COM 09062X103 254,621 5,497,000 SH DEFINED 1 5,497,000 NONE NONE Celgene COM 151020104 277,466 5,850,000 SH DEFINED 2 5,850,000 NONE NONE Cephalon COM 156708109 15,566 259,000 SH DEFINED 1 259,000 NONE NONE Elan Corp COM 284131208 47,595 2,850,000 SH DEFINED 2 2,850,000 NONE NONE Genentech COM 368710406 167,690 2,050,000 SH DEFINED 1 2,050,000 NONE NONE Genzyme COM 372917104 111,245 1,822,200 SH DEFINED 1 1,822,200 NONE NONE Gilead COM 375558103 208,605 3,526,109 SH DEFINED 1 3,526,109 NONE NONE Incyte COM 45337C102 13,800 3,000,000 SH DEFINED 3 3,000,000 NONE NONE Keryx Biopharmaceuticals COM 492515101 13,338 939,311 SH DEFINED 3 939,311 NONE NONE Onyx Pharmaceuticals COM 683399109 33,660 2,000,000 SH DEFINED 2 2,000,000 NONE NONE Rigel Pharmaceuticals COM 766559603 9,730 1,000,000 SH DEFINED 3 1,000,000 NONE NONE The Medicines Company COM 584688105 55,565 2,842,197 SH DEFINED 3 2,842,197 NONE NONE Vertex Pharmaceuticals COM 92532F100 110,130 3,000,000 SH DEFINED 3 3,000,000 NONE NONE Zymogenetics COM 98985T109 30,276 1,596,014 SH DEFINED 3 1,596,014 NONE NONE
-----END PRIVACY-ENHANCED MESSAGE-----